1. Home
  2. SCPH vs FGBI Comparison

SCPH vs FGBI Comparison

Compare SCPH & FGBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • FGBI
  • Stock Information
  • Founded
  • SCPH 2013
  • FGBI 1934
  • Country
  • SCPH United States
  • FGBI United States
  • Employees
  • SCPH N/A
  • FGBI N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • FGBI Savings Institutions
  • Sector
  • SCPH Health Care
  • FGBI Finance
  • Exchange
  • SCPH Nasdaq
  • FGBI Nasdaq
  • Market Cap
  • SCPH 179.6M
  • FGBI 158.1M
  • IPO Year
  • SCPH 2017
  • FGBI N/A
  • Fundamental
  • Price
  • SCPH $3.24
  • FGBI $10.21
  • Analyst Decision
  • SCPH Strong Buy
  • FGBI
  • Analyst Count
  • SCPH 2
  • FGBI 0
  • Target Price
  • SCPH $15.00
  • FGBI N/A
  • AVG Volume (30 Days)
  • SCPH 412.0K
  • FGBI 10.1K
  • Earning Date
  • SCPH 03-12-2025
  • FGBI 02-03-2025
  • Dividend Yield
  • SCPH N/A
  • FGBI 3.82%
  • EPS Growth
  • SCPH N/A
  • FGBI N/A
  • EPS
  • SCPH N/A
  • FGBI 0.85
  • Revenue
  • SCPH $30,278,000.00
  • FGBI $95,480,000.00
  • Revenue This Year
  • SCPH $172.64
  • FGBI N/A
  • Revenue Next Year
  • SCPH $131.43
  • FGBI $5.12
  • P/E Ratio
  • SCPH N/A
  • FGBI $12.51
  • Revenue Growth
  • SCPH 303.87
  • FGBI 0.27
  • 52 Week Low
  • SCPH $3.08
  • FGBI $8.39
  • 52 Week High
  • SCPH $6.54
  • FGBI $15.25
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 40.08
  • FGBI 30.09
  • Support Level
  • SCPH $3.27
  • FGBI $10.21
  • Resistance Level
  • SCPH $3.59
  • FGBI $10.85
  • Average True Range (ATR)
  • SCPH 0.20
  • FGBI 0.34
  • MACD
  • SCPH -0.01
  • FGBI -0.03
  • Stochastic Oscillator
  • SCPH 15.00
  • FGBI 0.00

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About FGBI First Guaranty Bancshares Inc.

First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.

Share on Social Networks: